A randomized, placebo‐controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER).
Saved in:
| Title: | A randomized, placebo‐controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER). |
|---|---|
| Authors: | Austin, Cary D.1 (AUTHOR) austin.cary@gene.com, Gonzalez Edick, Melissa1 (AUTHOR), Ferrando, Ronald E.1 (AUTHOR), Solon, Margaret1 (AUTHOR), Baca, Miriam1 (AUTHOR), Mesh, Kathryn1 (AUTHOR), Bradding, Peter2 (AUTHOR), Gauvreau, Gail M.3 (AUTHOR), Sumino, Kaharu4 (AUTHOR), FitzGerald, J. Mark5 (AUTHOR), Israel, Elliot6 (AUTHOR), Bjermer, Lief7 (AUTHOR), Bourdin, Arnaud8 (AUTHOR), Arron, Joseph R.1 (AUTHOR), Choy, David F.1 (AUTHOR), Olsson, Julie K.1 (AUTHOR), Abreu, Francis1 (AUTHOR), Howard, Monet1 (AUTHOR), Wong, Kit1 (AUTHOR), Cai, Fang1 (AUTHOR) |
| Source: | Clinical & Experimental Allergy. Dec2020, Vol. 50 Issue 12, p1342-1351. 10p. 2 Diagrams, 3 Charts, 2 Graphs. |
| Database: | Environment Complete |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 09547894 |
|---|---|
| DOI: | 10.1111/cea.13731 |
